Atlas Trials

Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence

Clinical trial NCT03512249 · COMPLETED

Trial details

NCT number
NCT03512249
Sponsor
International AIDS Vaccine Initiative
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis, Pulmonary
Start date
2019-01-31
Primary completion
2023-03-20
Enrollment
831

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.